vancomycin has been researched along with cefuroxime in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (9.64) | 18.7374 |
1990's | 12 (14.46) | 18.2507 |
2000's | 23 (27.71) | 29.6817 |
2010's | 33 (39.76) | 24.3611 |
2020's | 7 (8.43) | 2.80 |
Authors | Studies |
---|---|
Gokal, R; Marsden, A; Mistry, CD; Ramsden, R; Tooth, A; Were, AJ | 1 |
Denyer, SP; Finch, RG; Smith, DG; Wilcox, MH; Williams, P | 1 |
Edwards, R; Filik, R; Finch, RG; Wilcox, MH | 1 |
Baker, CJ; Butler, KM; Cheek, WR; Edwards, MS; Laurent, JP; Mason, EO | 1 |
Liu, C; Stratton, CW; Weeks, LS | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
Finch, R; Martin, J; Pilkington, R | 1 |
Frimodt-Møller, N; Thomsen, VF | 1 |
Adu, D; Curley, J; Gruer, LD; Michael, J; Turney, JH | 1 |
Anderson, AW; Cruickshank, JG | 1 |
Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES | 1 |
Daenen, SM; de Vries-Hospers, HG; Erjavec, Z; Halie, MR; van der Waaij, D; van Kamp, H | 1 |
de Araujo, B; Gordon, ES; Holman, J; Webb, LX; Zaccaro, DJ | 1 |
Barkholt, L; Edlund, C; Nord, CE; Olsson-Liljequist, B | 1 |
Pokela, R; Syrjälä, H; Vuorisalo, S | 2 |
Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
Vuorisalo, S | 1 |
Amorena, B; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
Dowell, SF; Leversedge, K; Smith, T; Snitzer, J | 1 |
Damen, J; Pelgrims, J; Schrijvers, D; Van Den Brande, J; Vermorken, J | 1 |
Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
Geyer, C; Gräfe, G; Handrik, W | 1 |
Crusius, S; Leber, W; Petzsch, M; Reisinger, EC; Westphal, B | 1 |
Betancor Martínez, L; García González, LA; Redondo Ventura, F | 1 |
Altintaş, O; Cağlar, Y; Etiler, N; Gündeş, S; Karabaş, VL; Ozkan, B | 1 |
Georgala, S; Krasagakis, K; Maniatakis, P; Samonis, G; Tosca, A | 1 |
Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M | 1 |
Cars, O; Karlsson, MO; Löwdin, E; Nielsen, EI; Sandström, M; Viberg, A | 1 |
Dao-Tran, TK; Davis, BR; Garey, KW; Gentry, LO; Hwang, LY; Lai, D | 1 |
Butler, L; Durrani, OM; Konstantinos, C; Mollan, AJ; Mollan, SP | 1 |
Bonde, M; Bygebjerg-Hove, I; Gottschalk, S; Gravesen, A; Kallipolitis, BH; Nguyen, TH; Nielsen, PK | 1 |
Aepinus, C; Podbielski, A; Schmialek, A; Schmitz, S; Zautner, AE | 1 |
Bartz-Schmidt, KU; Biedermann, T; Saygili, O; Spitzer, MS; Szurman, P; Tatar, O; Yoeruek, E | 1 |
Alqahtani, M; Ciccotelli, W; Cox, P; Low, D; Morris, S; Opavsky, M; Pillai, D; Poutanen, S | 1 |
Ewald, U; Friberg, LE; Honoré, PH; Nielsen, EI; Sandström, M | 1 |
Berisa, AE; Georgoulis, AD; Lykissas, MG; Manoudis, GN; Mitsionis, GI; Motsis, E; Sionti, I | 1 |
Ayşe, NB; Fatma, YM; Firdevs, O; Gülsen, Y; Necati, DM; Ozlem, TY | 1 |
Karageorgos, ACh; Lambiris, EE; Marangos, MN; Saridis, AG; Tyllianakis, ME | 1 |
Feyi-Waboso, A; Pegler, S; Raj, A | 1 |
Cars, O; Friberg, LE; Nielsen, EI | 2 |
Aziz, T; Bhatia, R; Dalton, A; Hopkins, C; Nandi, D; Richards, M | 1 |
Akar, M; Dilmen, U; Erdeve, O; Oguz, SS; Sandal, G; Uras, N | 1 |
Blackstone, EH; Gordon, SM; Koch, CG; Nowicki, ER; Rajeswaran, J; Sabik, JF | 1 |
Anderson, DJ; Devine, ST; Ford, KD; Kaye, KS | 1 |
Herrinton, LJ; Shorstein, NH; Winthrop, KL | 1 |
Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
Hung, YP; Ko, WC; Lee, CI; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wan, L; Wu, TC; Wu, YH | 1 |
Dong, H; Kang, CG; Lin, C; Wang, H; Ye, X; Zhao, YL | 1 |
Nguyen, ET; Shorstein, NH | 1 |
Helmann, JD; Lee, YH | 1 |
Alfonso, EC; Flynn, HW; Schimel, AM | 1 |
Campos-Mollo, E; Pérez-Canales, JL; Pérez-Santonja, JJ | 1 |
Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S | 1 |
Agraharam, D; Chandra Mohan, AK; Jayaramaraju, D; Kulkarni, S; Perumal, R; Shanmuganathan, R | 1 |
Braun, B; Cavanaugh, JE; Chiang, HY; Diekema, DJ; Hafner, J; Herwaldt, LA; Hickok, J; Moody, J; Perencevich, EN; Perlin, JB; Richards, CL; Schweizer, ML; Septimus, E; Ward, MA | 1 |
Kopell, BH; Rasouli, JJ | 1 |
Libre, PE; Mathews, S | 1 |
Ambati, BK; Bardsley, T; Bondalapati, S; Bowen, RC; Evans, PR; Greene, T; Kliethermes, M; Lawyer, TW; Mamalis, CA; McFarland, M; Rudnisky, CJ; Shi, D; Snow, KB; Zhou, AX | 1 |
Atkinson, A; Genoni, M; Kuster, SP; Marschall, J; Sommerstein, R; Thurneysen, M; Troillet, N; Widmer, AF | 1 |
Baba, T; Inoue, Y; Matsuura, K; Miyake, H; Miyazaki, D; Sasaki, SI; Shimizu, Y | 1 |
Arshinoff, SA; Felfeli, T; Modabber, M | 1 |
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC | 1 |
Bahmany, S; Barzel, I; Hunfeld, NGM; Jessurun, JG; Koch, BCP; van der Kuy, PHM | 1 |
Abdulla, A; Bos, K; de Winter, BCM; Koch, BCP; Muller, AE; Oosterhoff, M; van Oldenrijk, J; Zhao, Q | 1 |
Horita, N; Kaneko, T; Kato, A; Masuhara, N; Mizuki, N; Namkoong, H; Nomura, E; Takeuchi, M | 1 |
Arnold, PM; Chen, M; Garst, JR; Hassaneen, W; Ivankovic, S; MacInnis, B; Naik, A; Paisan, G; Shaffer, A | 1 |
Liu, CL; Liu, XT; Qiu, J; Wen, ZQ; Zhang, ZH; Zhu, SY | 1 |
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Calvo, J; Martínez-Martínez, L; Salas, C | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Duval, V; Glupczynski, Y; Joris, B; Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
Kaproń, B; Kosikowska, U; Malm, A; Plech, T; Wujec, M | 1 |
Kosikowska, U; Majewska, M; Malm, A; Plech, T; Wujec, M | 1 |
Ballav, S; Kerkar, S; Nagaraja, GK; Shama, P; Viveka, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Assennato, L; Calaresu, E; Cocuzza, C; Galletti, P; Giacomini, D; Guerrini, A; Martelli, G; Martinelli, M; Musumeci, R; Sacchetti, G | 1 |
Klein, CD; van Oosten, LN | 1 |
6 review(s) available for vancomycin and cefuroxime
Article | Year |
---|---|
The incidence of deep brain stimulator hardware infection: the effect of change in antibiotic prophylaxis regimen and review of the literature.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cohort Studies; Deep Brain Stimulation; Device Removal; Drug Therapy, Combination; Electrodes, Implanted; Female; Gentamicins; Humans; Male; Middle Aged; Prosthesis-Related Infections; Regression Analysis; Vancomycin | 2011 |
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections, Intraocular; Intraoperative Period; Moxifloxacin; Vancomycin | 2018 |
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Ciprofloxacin; Humans; Linezolid; Microbial Sensitivity Tests; Vancomycin | 2022 |
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; Moxifloxacin; Network Meta-Analysis; Postoperative Complications; Vancomycin | 2022 |
Perioperative prophylaxis for surgical site infections in pediatric spinal surgery: a systematic review and network meta-analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Child; Gentamicins; Humans; Network Meta-Analysis; Povidone-Iodine; Powders; Surgical Wound Infection; Vancomycin | 2023 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for vancomycin and cefuroxime
Article | Year |
---|---|
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aztreonam; Cefuroxime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tobramycin; Treatment Failure; Vancomycin | 1994 |
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Ecosystem; Enterococcus; Feces; Female; Genotype; Gram-Positive Cocci; Humans; Intestinal Mucosa; Intestines; Male; Middle Aged; Time Factors; Vancomycin | 1997 |
Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
Topics: Aged; Antibiotic Prophylaxis; Cefuroxime; Chromatography, High Pressure Liquid; Coronary Artery Bypass; Female; Humans; Intraoperative Period; Male; Middle Aged; Surgical Wound Infection; Vancomycin | 1997 |
Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Female; Finland; Humans; Male; Middle Aged; Surgery Department, Hospital; Surgical Wound Infection; Vancomycin | 1998 |
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Topics: Age Factors; Biomarkers; Body Weight; Cefuroxime; Creatinine; Cystatin C; Drug Interactions; Female; Gentamicins; Gestational Age; Humans; Indomethacin; Infant; Infant, Newborn; Infant, Premature; Male; Nonlinear Dynamics; Vancomycin | 2009 |
Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefuroxime; Fusidic Acid; Hip Prosthesis; Humans; Incidence; Knee Prosthesis; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2010 |
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cardiac Surgical Procedures; Cefazolin; Cefuroxime; Chlorhexidine; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Nose; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin; Young Adult | 2015 |
70 other study(ies) available for vancomycin and cefuroxime
Article | Year |
---|---|
Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
Topics: Adult; Aged; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pilot Projects; Random Allocation; Staphylococcal Infections; Vancomycin | 1992 |
Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Carbon Dioxide; Cefuroxime; Ciprofloxacin; Humans; Membrane Proteins; Polystyrenes; Reproducibility of Results; Silicone Elastomers; Staphylococcus; Vancomycin | 1991 |
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
Topics: Bacterial Adhesion; Catheters, Indwelling; Cefuroxime; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Silicone Elastomers; Staphylococcus epidermidis; Vancomycin | 1989 |
Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.
Topics: Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Humans; Infant; Injections, Intravenous; Vancomycin | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Dose-Response Relationship, Drug; Erythromycin; Gentamicins; In Vitro Techniques; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Vancomycin | 1987 |
Vancomycin and tobramycin in the treatment of CAPD peritonitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefuroxime; Coagulase; Drug Resistance, Microbial; Exudates and Transudates; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus; Streptococcus; Tobramycin; Vancomycin | 1985 |
Endocarditis due to viridans-type streptococci tolerant to beta-lactam antibiotics: therapeutic problems.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Endocarditis, Subacute Bacterial; Female; Humans; Male; Penicillin Resistance; Penicillins; Streptococcus mutans; Vancomycin | 1982 |
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin | 1995 |
Antibiotic resistance in staphylococci adherent to cortical bone.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Cefuroxime; Drug Resistance, Microbial; Humans; Methylmethacrylates; Nafcillin; Polytetrafluoroethylene; Staphylococcus; Tobramycin; Vancomycin | 1994 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Surgical site infections after coronary artery bypass surgery, with special reference to antibiotic prophylaxis and risk factors.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Female; Humans; Male; Risk Factors; Surgical Wound Infection; Vancomycin | 1998 |
Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cephalosporins; Male; Microbial Sensitivity Tests; Osteomyelitis; Predictive Value of Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1998 |
Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Lung; Male; Pneumonia, Pneumococcal; Radiography; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1999 |
Intraperitoneal treatment of peritoneo-venous shunt infection in a cancer patient.
Topics: Adult; Cefuroxime; Female; Fever; Humans; Infusions, Parenteral; Mesothelioma; Peritoneal Neoplasms; Peritoneovenous Shunt; Postoperative Complications; Treatment Outcome; Vancomycin | 2000 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Hydrocephalus internus--first manifestation of chronic meningitis due to Listeria monocytogenes.
Topics: Cefuroxime; Drug Therapy, Combination; Humans; Hydrocephalus; Infant; Meningitis, Listeria; Vancomycin; Ventriculoperitoneal Shunt | 2001 |
Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.
Topics: Abscess; Aged; Aorta, Thoracic; Aortic Valve; Cefuroxime; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Pericardial Effusion; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 2004 |
[Brain abscess secondary to rhinosinusitis. Therapeutical modalities. Exposition of one case].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Brain Abscess; Cefuroxime; Child; Dexamethasone; Drug Therapy, Combination; Ethmoid Sinusitis; Female; Humans; Tomography, X-Ray Computed; Vancomycin | 2004 |
Effect of vancomycin, teicoplanin, and cefuroxime on Staphylococcus epidermidis adherence to intraocular lenses.
Topics: Acrylic Resins; Anti-Bacterial Agents; Bacterial Adhesion; Cefuroxime; Colony Count, Microbial; In Vitro Techniques; Lenses, Intraocular; Polymethyl Methacrylate; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2005 |
Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Cloxacillin; Drug Therapy, Combination; Erysipelas; Female; Humans; Male; Methicillin; Methicillin Resistance; Middle Aged; Netilmicin; Penicillins; Skin; Staphylococcus; Treatment Outcome; Vancomycin | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin | 2006 |
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
Topics: Algorithms; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Dose-Response Relationship, Drug; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2007 |
Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Coagulase; Coronary Artery Bypass; Female; Humans; Incidence; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2008 |
Incidence of endophthalmitis following vitreoretinal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; United Kingdom; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
The two-component system CesRK controls the transcriptional induction of cell envelope-related genes in Listeria monocytogenes in response to cell wall-acting antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cefuroxime; Cell Wall; Ethanol; Gene Expression Regulation, Bacterial; Listeria monocytogenes; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Protein Kinases; Sequence Homology, Amino Acid; Transcription Factors; Transcription, Genetic; Vancomycin | 2008 |
Subcutaneous fistulae in a patient with femoral hypoplasia due to Actinomyces europaeus and Actinomyces turicensis.
Topics: Actinomyces; Actinomycosis; Antifungal Agents; Cefuroxime; Femur; Fistula; Humans; Immunocompetence; Knee Joint; Lower Extremity Deformities, Congenital; Male; RNA, Bacterial; RNA, Ribosomal, 16S; Soft Tissue Infections; Surgical Wound Infection; Vancomycin; Young Adult | 2009 |
Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use.
Topics: Annexin A5; Anti-Bacterial Agents; Apoptosis; Cefuroxime; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Corneal; Humans; Immunoenzyme Techniques; Membrane Proteins; Necrosis; Phosphoproteins; Vancomycin; Zonula Occludens-1 Protein | 2008 |
A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
Topics: Anti-Bacterial Agents; Cefuroxime; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infant; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin | 2008 |
Pyomyositis in children: early diagnosis and treatment.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Combined Modality Therapy; Dicloxacillin; Drainage; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Pyomyositis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2009 |
Are cefuroxime and vancomycin really safe on the corneal endothelial cells?
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Endothelium, Corneal; Malondialdehyde; Oxidative Stress; Rabbits; Thiobarbituric Acid Reactive Substances; Vancomycin | 2010 |
An unusual intracameral precipitation after trabeculectomy.
Topics: Anti-Bacterial Agents; Cefuroxime; Chemical Precipitation; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Postoperative Complications; Trabeculectomy; Vancomycin | 2010 |
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2011 |
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Cefuroxime; Computer Simulation; Erythromycin; Escherichia coli; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2011 |
Iliac osteomyelitis in a newborn: a case report.
Topics: Anti-Bacterial Agents; Blood; Cefuroxime; Humans; Ilium; Infant, Newborn; Methicillin; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
When the timing is right: Antibiotic timing and infection after cardiac surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefuroxime; Chi-Square Distribution; Comorbidity; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Ohio; Practice Guidelines as Topic; Prevalence; Prospective Studies; Registries; Risk Assessment; Risk Factors; Sternotomy; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Surgical site infection prophylaxis strategies for cardiothoracic surgery: a decision-analytic model.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefuroxime; Humans; Incidence; Linezolid; Oxazolidinones; Preoperative Care; Surgical Wound Infection; Survival Analysis; Thoracic Surgical Procedures; United States; Vancomycin | 2012 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; California; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Lens Implantation, Intraocular; Moxifloxacin; Phacoemulsification; Postoperative Complications; Quinolines; Vancomycin | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefepime; Cefuroxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Factors; Toll-Like Receptor 4; Vancomycin | 2013 |
Preliminary exploration of the development of a collagenous artificial dura mater for sustained antibiotic release.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Ceftriaxone; Cefuroxime; Collagen; Dura Mater; Vancomycin | 2013 |
Preparation of intracameral antibiotics for injection.
Topics: Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Chemistry, Pharmaceutical; Drug Compounding; Fluoroquinolones; Humans; Injections, Intraocular; Moxifloxacin; Quinolines; Vancomycin | 2013 |
Mutations in the primary sigma factor σA and termination factor rho that reduce susceptibility to cell wall antibiotics.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Biological Evolution; Cefuroxime; Cell Wall; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Genome, Bacterial; Mutation; Peptide Termination Factors; Sigma Factor; Vancomycin | 2014 |
Endophthalmitis prophylaxis for cataract surgery: are intracameral antibiotics necessary?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Gentamicins; Humans; Vancomycin | 2014 |
Corneal endothelial changes after intracameral vancomycin injection in cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Cell Count; Corneal Pachymetry; Endothelium, Corneal; Female; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Male; Prospective Studies; Vancomycin; Visual Acuity | 2015 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India.
Topics: Adolescent; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Cefuroxime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Injections, Intraocular; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Prospective Studies; Vancomycin | 2015 |
Successful reimplantation of extruded long bone segments in open fractures of lower limb--a report of 3 cases.
Topics: Accidents, Traffic; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; Debridement; Femoral Fractures; Fracture Healing; Fractures, Open; Humans; India; Male; Middle Aged; Replantation; Tibial Fractures; Treatment Outcome; Vancomycin | 2015 |
The Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burkholderia cepacia; Burkholderia Infections; Cefuroxime; Deep Brain Stimulation; Device Removal; Doxycycline; Dystonia; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Powders; Prosthesis Implantation; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2016 |
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Moxifloxacin; Postoperative Complications; Vancomycin | 2017 |
Antimicrobial prophylaxis and the prevention of surgical site infection in cardiac surgery: an analysis of 21 007 patients in Switzerland†.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefuroxime; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Switzerland; Time Factors; Vancomycin | 2019 |
Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Cell Survival; Cells, Cultured; Endothelial Cells; Esterases; Humans; Interleukin-8; Intravitreal Injections; Mice; Moxifloxacin; Pericytes; Retina; Vancomycin | 2019 |
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Cataract Extraction; Cefuroxime; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Vancomycin | 2019 |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy | 2021 |
Evaluation of the importance of mixing during preparation of antibiotic infusions.
Topics: Anti-Bacterial Agents; Cefuroxime; Floxacillin; Infusions, Intravenous; Meropenem; Vancomycin | 2022 |
[Distribution and Drug Resistance of Pathogens in Oral Mucositis Associated with Chemotherapy in Patients with Malignant Hematopathy].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Oral Ulcer; Penicillins; Stomatitis; Vancomycin | 2023 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
Topics: Actinomycetales; Anti-Bacterial Agents; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Line; Cephalosporins; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Keratinocytes; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phagocytosis; Ribonucleoproteins; Saccharomyces cerevisiae Proteins; Staphylococcus aureus | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Studies on the synthesis and antibacterial activity of 3,6-disubstituted 1,2,4-triazolo[3,4-b]1,3,4-thiadiazoles.
Topics: Anti-Bacterial Agents; Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiadiazoles | 2012 |
Microbiologically active Mannich bases derived from 1,2,4-triazoles. The effect of C-5 substituent on antibacterial activity.
Topics: | 2013 |
Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship | 2015 |
4-Alkyliden-azetidinones modified with plant derived polyphenols: Antibacterial and antioxidant properties.
Topics: Anti-Bacterial Agents; Antioxidants; Azetidines; Carbon-13 Magnetic Resonance Spectroscopy; Chromatography, High Pressure Liquid; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Polyphenols; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization | 2017 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |